Unnamed: 0,title,date,stock,sentiment
19771.0,28 Stocks Moving in Tuesday's Pre-Market Session,2020-05-19 07:20:00-04:00,ACST,neutral
19772.0,"Aegis Capital Maintains Buy on Acasti Pharma, Lowers Price Target of $2.15",2020-05-06 12:35:00-04:00,ACST,negative
19773.0,Acasti Pharma Announces Submission Of TRILOGY 1 Briefing Package To FDA,2020-04-30 08:30:00-04:00,ACST,neutral
19774.0,Acasti Pharma Reports Notice Of Allowance For Second Composition Of Matter Patent In Canada,2020-04-20 08:40:00-04:00,ACST,neutral
19775.0,10 Biotech Winners And Losers In Q1,2020-04-01 16:35:00-04:00,ACST,negative
19776.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,ACST,positive
19777.0,"The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company",2020-03-20 07:44:00-04:00,ACST,negative
19778.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-19 10:49:00-04:00,ACST,negative
19779.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,ACST,positive
19780.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-16 08:32:00-04:00,ACST,neutral
19781.0,Acasti Pharma Awarded Notice Of Allowance For Additional Composition Of Matter And Method Of Use Patents In The United States And Mexico,2020-03-11 08:14:00-04:00,ACST,positive
19782.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,ACST,negative
19783.0,Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements,2020-02-28 17:02:00-05:00,ACST,neutral
19784.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,ACST,negative
19785.0,50 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-28 08:34:00-05:00,ACST,neutral
19786.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,ACST,neutral
19787.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,ACST,negative
19788.0,Stocks That Hit 52-Week Lows On Wednesday,2020-02-26 11:14:00-05:00,ACST,negative
19789.0,10 Biggest Price Target Changes For Tuesday,2020-02-18 08:35:00-05:00,ACST,neutral
19790.0,"H.C. Wainwright Maintains Buy on Acasti Pharma, Lowers Price Target to $3",2020-02-18 07:12:00-05:00,ACST,negative
19791.0,Acasti Pharma Q3 EPS $(0.18) Down From $(0.05) YoY,2020-02-14 08:04:00-05:00,ACST,neutral
19792.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,ACST,positive
19793.0,80 Biggest Movers From Yesterday,2020-02-11 04:44:00-05:00,ACST,neutral
19794.0,Mid-Afternoon Market Update: Dow Rises 70 Points; vTv Therapeutics Shares Jump,2020-02-10 14:48:00-05:00,ACST,positive
19795.0,Mid-Day Market Update: Crude Oil Down Over 1%; Taubman Centers Shares Spike Higher,2020-02-10 12:23:00-05:00,ACST,negative
19796.0,58 Stocks Moving In Monday's Mid-Day Session,2020-02-10 12:14:00-05:00,ACST,neutral
19797.0,Stocks That Hit 52-Week Lows On Monday,2020-02-10 10:28:00-05:00,ACST,negative
19798.0,Mid-Morning Market Update: Markets Open Higher; Allergan Tops Q4 Expectations,2020-02-10 10:13:00-05:00,ACST,positive
19799.0,Acasti Pharma shares are trading lower after the company announced an investigation into its Phase 3 trials of CaPre is underway following 'inconsistent findings' that may have negatively impacted results in its TRILOGY 1 trial.,2020-02-10 08:15:00-05:00,ACST,neutral
19800.0,12 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-02-10 07:51:00-05:00,ACST,neutral
19801.0,8 Biotechnology Stocks Moving In Monday's Pre-Market Session,2020-02-10 07:50:00-05:00,ACST,neutral
19802.0,30 Stocks Moving in Monday's Pre-Market Session,2020-02-10 07:30:00-05:00,ACST,neutral
19803.0,"UPDATE: Acasti Says Plans To Seek FDA Guidance Prior To Unblinding TRILOGY 2 Data, Expected To Delay Reporting To Topline Results Until Calendar Q3'20",2020-02-10 07:08:00-05:00,ACST,negative
19804.0,"Acasti Pharma Offers Update On TRILOGY 1, 2 Phase 3 Trials Of CaPre: Probe Underway Into Unexpected, Inconsistent Findings That May Have Negatively Impacted Results Of TRILOGY 1",2020-02-10 07:07:00-05:00,ACST,neutral
19805.0,8 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-05 07:43:00-05:00,ACST,neutral
19806.0,6 Biotechnology Stocks Moving In Wednesday's Pre-Market Session,2020-02-05 07:42:00-05:00,ACST,neutral
19807.0,Shares of several healthcare companies are trading higher in sympathy with the overall market on a rebound after increased fear of the Wuhan coronavirus' impact on the economy dropped the Dow roughly 600 points on Friday.,2020-02-03 11:13:00-05:00,ACST,positive
19808.0,34 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-01-15 08:10:00-05:00,ACST,neutral
19809.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,ACST,positive
19810.0,13 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-01-14 07:44:00-05:00,ACST,neutral
19811.0,85 Biggest Movers From Yesterday,2020-01-14 04:52:00-05:00,ACST,neutral
19812.0,Mid-Afternoon Market Update: Acasti Pharma Falls On Failed Late-Stage Trial; Verona Pharma Shares Gain,2020-01-13 15:40:00-05:00,ACST,positive
19813.0,Mid-Day Market Update: Crude Oil Down Over 1%; Dare Bioscience Shares Spike Higher,2020-01-13 12:27:00-05:00,ACST,negative
19814.0,41 Stocks Moving In Monday's Mid-Day Session,2020-01-13 12:21:00-05:00,ACST,neutral
19815.0,"Acasti Shares Slump On Failed Late-Stage Trial, Amarin Moves In Sympathy",2020-01-13 12:18:00-05:00,ACST,positive
19816.0,"B. Riley FBR Downgrades Acasti Pharma to Neutral, Announces $2 Price Target",2020-01-13 11:09:00-05:00,ACST,neutral
19817.0,Mid-Morning Market Update: Markets Open Higher; Cott To Acquire Primo Water,2020-01-13 10:25:00-05:00,ACST,neutral
19818.0,Acasti Pharma shares are trading lower after the company announced its TRILOGY 1 Phase 3 trial of CaPre did not reach statistical significance.,2020-01-13 07:17:00-05:00,ACST,negative
19819.0,Acasti Pharma Says its TRILOGY 1 Phase 3 Trial of CaPre Did Not Reach Statistical Significance,2020-01-13 06:29:00-05:00,ACST,negative
19820.0,50 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-01-08 08:31:00-05:00,ACST,neutral
19821.0,31 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-12-27 08:13:00-05:00,ACST,neutral
19822.0,60 Biggest Movers From Yesterday,2019-12-27 04:44:00-05:00,ACST,neutral
19823.0,34 Stocks Moving In Thursday's Mid-Day Session,2019-12-26 12:11:00-05:00,ACST,neutral
19824.0,Acasti Pharma shares are trading higher on a rebound after the stock price dropped on December 23rd after releasing news surrounding its TRILOGY 1 trial.,2019-12-26 10:56:00-05:00,ACST,positive
19825.0,Acasti Delays Data Readout For Drug To Treat Elevated Triglycerides,2019-12-24 09:51:00-05:00,ACST,positive
19826.0,"Acasti Pharma Shares Resume Trade, Move Lower, Down ~$0.20-$0.40",2019-12-24 09:15:00-05:00,ACST,neutral
19827.0,Acasti Pharma Shares To Resume Trade At 9:15 a.m. EST,2019-12-24 08:58:00-05:00,ACST,positive
19828.0,"Benzinga Pro's Top 5 Stocks To Watch For Tues., Dec. 24, 2019: TSLA, WCC, ACST, YMAB, ITCI",2019-12-24 08:13:00-05:00,ACST,positive
19829.0,"The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict",2019-12-24 07:24:00-05:00,ACST,negative
19830.0,"UPDATE: Acasti Postpones Topline Results For TRILOGY 1 Phase 3 Trial Of CaPre From Dec. 2019 To Jan. 2020, Cites 'unexpected delay in data processing, transfer from central testing labs to statistical consultants for independent, external validation'",2019-12-24 07:11:00-05:00,ACST,negative
19831.0,78 Biggest Movers From Yesterday,2019-12-24 04:32:00-05:00,ACST,neutral
19832.0,Acasti Expects to Report Trilogy 1 Topline Results in January 2020 With Topline Results for Trilogy 2 Still Expected by End of January 2020; Says Implementation of Trilogy 2 Study Remains on Track,2019-12-23 20:35:00-05:00,ACST,neutral
19833.0,Acasti Pharma Shares Halted News Pending,2019-12-23 13:26:00-05:00,ACST,positive
19834.0,"BZ NOTE On Acasti Pharma Price Action: On Nov. 26, 2019, Co. Issued Press Release Highlighting The Last Patient Visit In Its TRILOGY 1 Trial For Hypertriglceridemia Treatment, Said Was On Track For Topline Results In Dec.",2019-12-23 13:21:00-05:00,ACST,positive
19835.0,"Acasti Pharma Shares Halted On Circuit Breaker As Shares Rebound From Low; Up ~38% From Session Low, Down 43% For Session",2019-12-23 13:17:00-05:00,ACST,positive
19836.0,"Acasti Pharma Shares Resume Trade, Down 55%",2019-12-23 13:15:00-05:00,ACST,positive
19837.0,"Acasti Pharma Shares Halted On Second Circuit Breaker, Down 46.7%",2019-12-23 13:10:00-05:00,ACST,positive
19838.0,Acasti Pharma Shares Resume Trade,2019-12-23 13:08:00-05:00,ACST,positive
19839.0,"Seeing Large Dip In Acasti Pharma Shares, Down 29.62% For Session; Shares Currently Halted",2019-12-23 13:07:00-05:00,ACST,positive
19840.0,Acasti Pharma Shares Halted On Circuit Breaker,2019-12-23 13:05:00-05:00,ACST,positive
19841.0,Stocks That Hit 52-Week Highs On Monday,2019-12-23 10:20:00-05:00,ACST,neutral
19842.0,16 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-12-23 07:50:00-05:00,ACST,neutral
19843.0,60 Biggest Movers From Friday,2019-12-23 05:37:00-05:00,ACST,neutral
19844.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-12-20 08:19:00-05:00,ACST,neutral
19845.0,30 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-12-18 08:11:00-05:00,ACST,neutral
19846.0,68 Biggest Movers From Yesterday,2019-12-18 04:56:00-05:00,ACST,neutral
19847.0,Acasti Pharma shares are trading higher on seemingly no company-specific news. The stock is trading on higher-than-average volume. NOTE: Penny stocks can have volatile price action with no catalyst.,2019-12-17 13:05:00-05:00,ACST,negative
19848.0,24 Stocks Moving in Monday's Pre-Market Session,2019-12-16 07:27:00-05:00,ACST,neutral
19849.0,Acasti Pharma shares are trading higher. Not seeming any company-specific news to justify the price action.,2019-12-13 14:53:00-05:00,ACST,positive
19850.0,"Acasti Pharma Reports Last Patient Visit In TRILOGY 1 Phase 3 Trial Of CaPre For Treatment Of Severe Hypertriglyceridemia, Says On Track To Support Topline Results For TRILOGY 1 In Dec., TRILOGY 2 In Jan. 2020",2019-11-26 07:56:00-05:00,ACST,neutral
19851.0,63 Biggest Movers From Yesterday,2019-11-21 04:49:00-05:00,ACST,neutral
19852.0,38 Stocks Moving In Wednesday's Mid-Day Session,2019-11-20 12:09:00-05:00,ACST,neutral
19853.0,33 Stocks Moving in Wednesday's Pre-Market Session,2019-11-20 07:16:00-05:00,ACST,neutral
19854.0,"B. Riley FBR Reinstates Buy on Acasti Pharma, Announces $8 Price Target",2019-11-18 11:03:00-05:00,ACST,neutral
19855.0,30 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-15 08:14:00-05:00,ACST,neutral
19856.0,35 Stocks Moving in Friday's Pre-Market Session,2019-11-15 07:52:00-05:00,ACST,neutral
19857.0,19 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-14 07:35:00-05:00,ACST,neutral
19858.0,Acasti Pharma Q2 EPS $(0.34) Misses $(0.16) Estimate,2019-11-13 07:57:00-05:00,ACST,negative
19859.0,Acasti Pharma shares are trading higher despite no company-specific news. The stock is trading on higher-than-average volume.,2019-11-12 10:38:00-05:00,ACST,positive
19860.0,"Acasti Pharma Reports Partnership With Aker BioMarine To Deliver Krill Oil To Co. Under 2-Year Deal, No Terms Disclosed",2019-11-04 09:05:00-05:00,ACST,negative
19861.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-11 08:42:00-04:00,ACST,neutral
19862.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-02 08:54:00-04:00,ACST,neutral
19863.0,18 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-09-30 08:44:00-04:00,ACST,neutral
19864.0,Acasti Pharma Announces Phase 3 Milestones Achieved,2019-09-30 08:38:00-04:00,ACST,neutral
19865.0,23 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-25 08:17:00-04:00,ACST,neutral
19866.0,27 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-09-09 08:42:00-04:00,ACST,neutral
19867.0,Acasti Pharma Receives Funding From The Government Of Canada To Expand Production Capacity,2019-09-09 08:38:00-04:00,ACST,positive
19868.0,"UPDATE: B. Riley FBR On Acasti Pharma Also Notes 'CaPre could be the best-in-class omega-3 fatty acid drug and could capture a large share of the market, even without a first-to-market advantage. We project >C$100M in sales revenue in FY24'",2019-08-29 11:10:00-04:00,ACST,positive
19869.0,"Update: B. Riley FBR Initiates Acasti Pharma With Buy, $7.75 Target 'based on expectations of positive Phase III results in early 1Q20 with leading drug candidate, CaPre'",2019-08-29 11:10:00-04:00,ACST,positive
19870.0,"B. Riley FBR Initiates Coverage On Acasti Pharma with Buy Rating, Announces $7.75 Price Target",2019-08-29 11:07:00-04:00,ACST,neutral
19871.0,23 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-08-29 08:40:00-04:00,ACST,neutral
19872.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-08-20 08:32:00-04:00,ACST,neutral
19873.0,33 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-08-19 08:47:00-04:00,ACST,neutral
19874.0,75 Biggest Movers From Yesterday,2019-08-16 05:16:00-04:00,ACST,neutral
19875.0,32 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-14 08:50:00-04:00,ACST,neutral
19876.0,Acasti Pharma Q1 EPS $(0.15) Beats $(0.16) Estimate,2019-08-14 08:15:00-04:00,ACST,neutral
19877.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market amid growing concerns over the U.S.-China trade war. This morning, President Trump announced the U.S. will not be doing business with Huawei.",2019-08-09 13:23:00-04:00,ACST,negative
19878.0,31 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-09 09:00:00-04:00,ACST,neutral
19879.0,50 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-08 21:56:00-04:00,ACST,neutral
19880.0,70 Biggest Movers From Yesterday,2019-08-06 04:46:00-04:00,ACST,neutral
19881.0,40 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-02 04:10:00-04:00,ACST,neutral
19882.0,88 Biggest Movers From Yesterday,2019-08-01 05:41:00-04:00,ACST,neutral
19883.0,71 Stocks Moving In Wednesday's Mid-Day Session,2019-07-31 12:32:00-04:00,ACST,neutral
19884.0,"The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster",2019-07-31 07:06:00-04:00,ACST,negative
19885.0,28 Healthcare Stocks Moving In Tuesday's After-Market Session,2019-07-31 04:01:00-04:00,ACST,neutral
19886.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Screener Tool For Tue., July 30, 2019",2019-07-30 13:57:00-04:00,ACST,positive
19887.0,New Stocks that Broke Through 52-Week Highs Tuesday Morning,2019-07-30 10:34:00-04:00,ACST,negative
19888.0,33 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-30 09:16:00-04:00,ACST,neutral
19889.0,42 Stocks Moving In Tuesday's Pre-Market Session,2019-07-30 08:14:00-04:00,ACST,neutral
19890.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,ACST,positive
19891.0,54 Biggest Movers From Yesterday,2019-07-30 05:00:00-04:00,ACST,neutral
19892.0,45 Healthcare Stocks Moving In Monday's After-Market Session,2019-07-30 04:54:00-04:00,ACST,neutral
19893.0,Acasti Pharma shares are trading higher on seemingly no company-specific news.,2019-07-29 13:40:00-04:00,ACST,neutral
19894.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Screener Tool For Mon., July 29, 2019",2019-07-29 12:22:00-04:00,ACST,positive
19895.0,New Equities that Broke Through 52-Week Highs Monday Morning,2019-07-29 10:13:00-04:00,ACST,negative
19896.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,ACST,neutral
19897.0,62 Biggest Movers From Friday,2019-07-29 05:47:00-04:00,ACST,neutral
19898.0,45 Stocks Moving In Friday's Mid-Day Session,2019-07-26 14:17:00-04:00,ACST,neutral
19899.0,30 Healthcare Stocks Moving In Thursday's After-Market Session,2019-07-26 04:36:00-04:00,ACST,neutral
19900.0,Acasti Pharma Comments On Trading Activity And Reaffirms No Plans To Raise Capital,2019-07-25 15:44:00-04:00,ACST,negative
19901.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Screener Tool For Thu., July 25, 2019",2019-07-25 13:49:00-04:00,ACST,positive
19902.0,25 Stocks Moving In Thursday's Pre-Market Session,2019-07-25 07:28:00-04:00,ACST,neutral
19903.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,ACST,negative
19904.0,50 Biggest Movers From Yesterday,2019-07-25 05:50:00-04:00,ACST,neutral
19905.0,38 Stocks Moving In Wednesday's Mid-Day Session,2019-07-24 13:57:00-04:00,ACST,neutral
19906.0,Acasti Pharma shares are trading higher on seemingly no company-specific news. Shares have gained since the stock broke the $2.10 level.,2019-07-24 12:17:00-04:00,ACST,positive
19907.0,24 Stocks Moving In Wednesday's Pre-Market Session,2019-07-24 07:58:00-04:00,ACST,neutral
19908.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Screener Tool For Tue., July 23, 2019",2019-07-23 13:52:00-04:00,ACST,positive
19909.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,ACST,negative
19910.0,Acasti Pharma shares are trading higher after Oppenheimer initiated coverage on the company's stock with an Outperform rating and a $7 price target.,2019-07-18 13:12:00-04:00,ACST,positive
19911.0,"Benzinga's Top Upgrades, Downgrades For July 18, 2019",2019-07-18 09:18:00-04:00,ACST,positive
19912.0,"Oppenheimer Initiates Coverage On Acasti Pharma with Outperform Rating, Announces $7 Price Target",2019-07-18 07:39:00-04:00,ACST,neutral
19913.0,"A Look At Benzinga Pro's Most-Searched Tickers For June 27, 2019",2019-06-27 11:37:00-04:00,ACST,neutral
19914.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Thursday, June 27, 2019",2019-06-27 10:04:00-04:00,ACST,positive
19915.0,54 Biggest Movers From Yesterday,2019-06-27 04:54:00-04:00,ACST,neutral
19916.0,44 Stocks Moving In Wednesday's Mid-Day Session,2019-06-26 12:17:00-04:00,ACST,neutral
19917.0,"A Look At Benzinga Pro's Most-Searched Tickers For June 26, 2019",2019-06-26 11:22:00-04:00,ACST,neutral
19918.0,Acasti Pharma Trades Higher Despite 'Material Uncertainty',2019-06-26 11:08:00-04:00,ACST,positive
19919.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wednesday, June 26, 2019",2019-06-26 10:13:00-04:00,ACST,positive
19920.0,28 Stocks Moving In Wednesday's Pre-Market Session,2019-06-26 08:08:00-04:00,ACST,neutral
19921.0,Acasti Pharma Says There Exists A Material Uncertainty About Co.'s Ability To Continue As A Going Concern.,2019-06-26 08:08:00-04:00,ACST,neutral
19922.0,"H.C. Wainwright Initiates Coverage On Acasti Pharma with Buy Rating, Announces $6 Price Target",2019-06-26 07:32:00-04:00,ACST,neutral
19923.0,Acasti Pharma shares are trading higher on continued strength after a bullish blog post was published on Seeking Alpha on Tuesday.,2019-06-26 07:10:00-04:00,ACST,positive
19924.0,51 Biggest Movers From Yesterday,2019-06-26 05:53:00-04:00,ACST,neutral
19925.0,"Earnings Scheduled For June 26, 2019",2019-06-26 04:34:00-04:00,ACST,neutral
19926.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-06-25 12:44:00-04:00,ACST,neutral
19927.0,Acasti Pharma shares are trading higher following a bullish Seeking Alpha blog post that mentioned potential valuation around $55 per share.,2019-06-25 12:00:00-04:00,ACST,positive
19928.0,Acasti Pharma Shares Moving Higher Following Bullish Blog Post Mentioning Potential Valuation Around $55/Share,2019-06-25 11:56:00-04:00,ACST,positive
19929.0,Acasti Pharma Awarded Notice Of Allowance For Second Patent In China Covering CaPre's Omega-3 Phospholipid Composition,2019-06-24 09:06:00-04:00,ACST,positive
19930.0,Acasti Pharma shares are trading higher after the company reported its TRILOGY 2 Trial achieved 100% patient randomization target in patients with severe Hypertriglyceridemia.,2019-06-04 14:35:00-04:00,ACST,negative
19931.0,44 Stocks Moving In Tuesday's Mid-Day Session,2019-06-04 12:44:00-04:00,ACST,neutral
19932.0,Acasti Pharma Reports TRILOGY 2 Trial Achieved 100% Patient Randomization Target In Patients With Severe Hypertriglyceridemia,2019-06-04 09:16:00-04:00,ACST,negative
19933.0,"Acasti Pharma Reports Notices Of Allowance For Added Composition, Use Patents In Mexico, Chile, Israel",2019-05-15 08:09:00-04:00,ACST,neutral
19934.0,Acasti Reports Settled Claims With Former CEO; Co. Agreed To Issue 900K Shares Of Common Stock From Treasury To Former CEO,2019-05-10 07:46:00-04:00,ACST,positive
19935.0,Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization In Patients With Severe Hypertriglyceridemia,2019-04-15 09:16:00-04:00,ACST,negative
19936.0,"Acasti Pharma, Inc. Q3 EPS $(0.07) Beats $(0.16) Estimate",2019-02-14 08:30:00-05:00,ACST,neutral
19937.0,Acasti Pharma Awarded Broad Composition-of-Matter And Method Of Use Patents By European Patent Office,2019-01-09 08:07:00-05:00,ACST,positive
19938.0,"Acasti Pharma Reports 100+ Patients Have Completed 6-Month Treatment Plan Related To TRILOGY Phase 3 Trials Of CaPre For Severe Hypertriglyceridemia, 65% Randomization Level Exceeded",2018-12-31 08:07:00-05:00,ACST,negative
19939.0,Acasti Pharma Reports Achieved Planned Enrollment Targets For TRILOGY Phase 3 Trials Of CaPre In Patients With Sever Hypertriglyceridemia,2018-12-20 08:08:00-05:00,ACST,neutral
19940.0,"Acasti Pharma Shares Resume Trade, Down 5.7%",2018-10-04 10:16:00-04:00,ACST,positive
19941.0,Acasti Pharma Shares To Resume Trade At 10:15 a.m. ET,2018-10-04 09:48:00-04:00,ACST,positive
19942.0,Acasti Pharma Prices 16.6M Share Common Stock Offering At $1.00/Share,2018-10-04 09:36:00-04:00,ACST,positive
19943.0,Acasti Pharma Shares Halted With Code News Pending,2018-10-04 09:35:00-04:00,ACST,positive
19944.0,"The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut",2018-10-04 07:59:00-04:00,ACST,neutral
19945.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-10-04 07:58:00-04:00,ACST,neutral
19946.0,"10 Stocks To Watch For October 4, 2018",2018-10-04 04:12:00-04:00,ACST,neutral
19947.0,Acasti Pharma shares are down 11.6% after the company reported a common stock offering.,2018-10-03 16:43:00-04:00,ACST,positive
19948.0,"Acasti Pharma Reports Common Stock Offering, No Size Disclosed",2018-10-03 16:24:00-04:00,ACST,negative
19949.0,45 Biggest Movers From Yesterday,2018-10-03 05:40:00-04:00,ACST,neutral
19950.0,Mid-Afternoon Market Update: Stitch Fix Falls After Q4 Results; Pyxus International Shares Climb,2018-10-02 14:31:00-04:00,ACST,positive
19951.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-10-02 13:51:00-04:00,ACST,neutral
19952.0,"The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",2018-10-02 09:10:00-04:00,ACST,positive
19953.0,24 Stocks Moving In Tuesday's Pre-Market Session,2018-10-02 08:05:00-04:00,ACST,neutral
19954.0,A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street,2018-10-02 06:47:00-04:00,ACST,negative
19955.0,"5 Stocks To Watch For October 2, 2018",2018-10-02 04:03:00-04:00,ACST,neutral
19956.0,Acasti Pharma Reports Offering Of Common Shares To Holders Of Its Outstanding Convertible Debentures,2018-10-01 17:00:00-04:00,ACST,positive
19957.0,"Acasti Pharma shares are up 31.4%; Acasti is a subsidiary of Neptune Wellness Solutions, which is Is up 18.3% as traders circulate its investor day presentation highlighting Nabisco beverages and edibles.",2018-10-01 13:25:00-04:00,ACST,positive
19958.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Oct. 1, 2018",2018-10-01 13:17:00-04:00,ACST,positive
19959.0,"Acasti Pharma, Inc. - Class A Common Stock Q1 EPS $(0.23) Misses $(0.16) Estimate",2018-08-14 13:02:00-04:00,ACST,negative
19960.0,"The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut",2018-08-14 08:23:00-04:00,ACST,neutral
19961.0,"Stocks Which Set New 52-Week Low Yesterday, August 9th",2018-08-10 10:05:00-04:00,ACST,negative
19962.0,"Acasti Pharma Shares Up 11% On High Volume, ~2x Daily Avg.",2018-07-31 11:50:00-04:00,ACST,positive
19963.0,34 Stocks Moving In Tuesday's Mid-Day Session,2018-07-24 12:28:00-04:00,ACST,neutral
19964.0,Benzinga Pro's 5 Stocks To Watch Today,2018-07-24 09:15:00-04:00,ACST,neutral
19965.0,"Acasti Pharma Shares Up 13% Premarket After Co. Received Composition-Of-Matter Patent From US Patent And Trademark Office For Phoshpolipid Structure of CaPre, Co.'s Lead Candidate For Treatment Of Hypertriglyceridemia",2018-07-24 08:57:00-04:00,ACST,positive
19966.0,Acasti Pharma Awarded Composition-Of-Matter Patent By U.S. Patent And Trademark Office,2018-07-24 07:15:00-04:00,ACST,positive
19967.0,"Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut",2018-06-28 08:26:00-04:00,ACST,positive
19968.0,Acasti Pharma Reports Q4 EPS $0.32 Up From $(0.33) YoY,2018-06-27 17:01:00-04:00,ACST,neutral
19969.0,"Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway",2018-05-09 07:48:00-04:00,ACST,neutral
19970.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,ACST,neutral
19971.0,"Benzinga's Biotech Pulse: Takeda Sweetens Shire Offer Again, Menlo's Woes Abound, Earnings Fail to Boost Amgen",2018-04-25 07:46:00-04:00,ACST,negative
19972.0,"Acasti Pharma Shares Resume Trade, Down 20.8%",2018-04-24 13:00:00-04:00,ACST,positive
19973.0,"UPDATE: Acasti Said Offering, Together With Cash On Hand, Intended To Be Used For 'further development of CaPre® and the continued advancement of the Company's Phase 3 program'",2018-04-24 12:59:00-04:00,ACST,positive
19974.0,"Acasti Pharma Shares To Resume Trade At 1 p.m. EDT; Co. Earlier Announced In 6-K Filing Overnight Marketed Canadian Public Unit Offering, No Terms Disclosed",2018-04-24 12:58:00-04:00,ACST,neutral
19975.0,Acasti Pharma Shares Halted News Pending,2018-04-23 15:42:00-04:00,ACST,positive
19976.0,Acasti Pharma Announces the Issuance of 30K Common Shares to Satisfy an Interest Payment,2018-04-02 08:38:00-04:00,ACST,positive
19977.0,Acasti Pharma Reports First Patient Randomized In Pivotal TRILOGY Phase 3 Program Of CaPre In Severe Hypertriglyceridemia,2018-03-14 08:07:00-04:00,ACST,negative
19978.0,"Acasti Pharma Shares Spike To Session Highs, Up 3-4%, As Traders Circulate data.epo.org Specification For Concentrated Therapeutic Phospholipid Compositions Patent",2018-02-21 10:23:00-05:00,ACST,positive
19979.0,Acasti Pharma Reports Q3 EPS $(0.40) vs $(0.22) In Same Qtr. Last Year,2018-02-13 17:02:00-05:00,ACST,neutral
19980.0,Hearing Dawson James Initiates Acasti Pharma Witha Buy And $2.40 Price Target,2018-01-29 09:50:00-05:00,ACST,neutral
19981.0,Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures Of $2M,2018-01-08 07:10:00-05:00,ACST,positive
19982.0,"Benchmark Initiates Coverage On Acasti Pharma with Speculative Buy Rating, Announces $7.00 Price Target",2018-01-05 07:08:00-05:00,ACST,positive
19983.0,"Acasti Expands Global Patent Portfolio with Newly Granted Patents in South Korea and Canada, Granted Patents Are Valid Until 2030",2018-01-04 08:06:00-05:00,ACST,positive
19984.0,Acasti Pharma Announces Closing of US$10 Million Firm Commitment Offering of Common Shares and Warrants,2017-12-27 16:08:00-05:00,ACST,positive
19985.0,Acasti Pharma Prices $10M Offering Of Shares And Warrants,2017-12-21 08:55:00-05:00,ACST,positive
19986.0,45 Biggest Movers From Yesterday,2017-11-28 05:21:00-05:00,ACST,neutral
19987.0,40 Biggest Movers From Yesterday,2017-11-22 05:03:00-05:00,ACST,neutral
19988.0,Acasti Pharma Shares Down 24.84% Amid Likely Profit Taking Following Big Upside Monday On Announcement Of Co. Holding Discussions With Chinese Pharma Partner,2017-11-21 13:06:00-05:00,ACST,positive
19989.0,40 Stocks Moving In Tuesday's Mid-Day Session,2017-11-21 12:42:00-05:00,ACST,neutral
19990.0,33 Stocks Moving In Tuesday's Pre-Market Session,2017-11-21 08:08:00-05:00,ACST,neutral
19991.0,"Acasti Pharma Announces Development and Commercialization Discussions Progressing with a Leading China Pharmaceutical Partner, Tentative Terms Include a $8M Upfront Payment",2017-11-20 08:09:00-05:00,ACST,neutral
19992.0,Acasti Pharma Reports Q2 EPS $(0.31) vs $(0.22) In Same Qtr. Last Year,2017-11-13 17:33:00-05:00,ACST,neutral
19993.0,Acasti Pharma Reports Q1 EPS $(0.19) vs $(0.29) In Same Qtr. Last Year,2017-08-14 17:32:00-04:00,ACST,neutral
19994.0,Acasti Pharma Reports Q4 EPS $(0.23) vs $(0.18) In Same Qtr. Last Year,2017-06-06 16:32:00-04:00,ACST,neutral
19995.0,"Acasti Pharma, CordenPharma Reports Large Scale Production of CaPre with New Continuous Manufacturing Process",2017-05-31 08:04:00-04:00,ACST,neutral
19996.0,"Acasti Pharma Reports Granted Added Composition & Use Patents in Taiwan, Australia",2017-04-24 08:03:00-04:00,ACST,positive
19997.0,Mid-Afternoon Market Update: Dow Rises Over 50 Points; Exfo Shares Tumble,2017-03-30 15:07:00-04:00,ACST,positive
19998.0,15 Biggest Mid-Day Gainers For Thursday,2017-03-30 12:39:00-04:00,ACST,neutral
19999.0,Mid-Day Market Update: Crude Oil Up Over 1.5%; Cartesian Shares Slide,2017-03-30 12:22:00-04:00,ACST,negative
20000.0,Acasti Pharma Plans To Proceed With Phase 3 CaPRe Program Following Recent End-of-PHase 2 Meeting With FDA,2017-03-30 08:04:00-04:00,ACST,neutral
20001.0,15 Biggest Mid-Day Gainers For Monday,2017-01-23 12:30:00-05:00,ACST,neutral
20002.0,15 Biggest Mid-Day Gainers For Friday,2016-12-23 12:31:00-05:00,ACST,neutral
20003.0,Mid-Morning Market Update: Markets Edge Higher; Cal-Maine Sales Miss Estimates,2016-12-23 10:08:00-05:00,ACST,negative
20004.0,18 Biggest Mid-Day Losers For Wednesday,2016-11-30 12:57:00-05:00,ACST,negative
20005.0,15 Biggest Mid-Day Gainers For Tuesday,2016-11-29 12:32:00-05:00,ACST,neutral
20006.0,Acasti Pharma Announces Linda O'Keefe CFO,2016-11-28 08:04:00-05:00,ACST,neutral
20007.0,Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre,2016-10-26 08:01:00-04:00,ACST,positive
20008.0,Acasti Pharma Reports Q2 EP S$(0.22) vs. Prior Year Quarter $(0.12),2016-10-11 17:01:00-04:00,ACST,neutral
20009.0,15 Biggest  Mid-Day Losers For Thursday,2016-09-15 16:36:00-04:00,ACST,negative
20010.0,"Acasti Pharma Shares Break Out Over $1.70, $2, More Recently $2.50 Levels Over Last Hour; Stock Now Up 109% for Session Following Earlier Positive Data on CaPre Omega-3 Bridging Study Data",2016-09-14 15:07:00-04:00,ACST,positive
20011.0,BZ NOTE: Watch Neptune Tech Shares On Spike Higher in Acasti Pharma Shares; ACST is Now Up 96% for Session,2016-09-14 15:02:00-04:00,ACST,positive
20012.0,12 Biggest Mid-Day Gainers For Wednesday,2016-09-14 12:51:00-04:00,ACST,neutral
20013.0,Mid-Morning Market Update: Markets Edge Higher; Bayer To Buy Monsanto For $66B,2016-09-14 09:53:00-04:00,ACST,neutral
20014.0,Acasti Pharma Reports Positive CaPre Omega-3 Bridging Study Data,2016-09-14 08:06:00-04:00,ACST,positive
20015.0,Jan D'Alvise Named President & CEO of Acasti Pharma,2016-05-12 08:11:00-04:00,ACST,neutral
20016.0,Acasti Reports Q3 Adj. EBITDA ($5.418M) vs. Prior Year Quarter ($6.244M),2016-01-12 17:08:00-05:00,ACST,neutral
20017.0,"Acasti, Neptune Enter Into Transactional Arrangement",2016-01-07 20:45:00-05:00,ACST,neutral
20018.0,Acasti Pharma Says Received Positive Feedback from FDA on Proposed Development Pathway for Capre,2015-12-16 07:54:00-05:00,ACST,positive
20019.0,"Acasti Says FDA Provided Encouraging Response On CaPre Clinical Development, Seeking Formal Approval To Start Bioavailability Bridging Study",2015-12-16 07:54:00-05:00,ACST,positive
20020.0,"Acasti Reports Q2 Net Loss $1.241M, Adj. EBITDA Loss $1.485B",2015-10-14 17:10:00-04:00,ACST,negative
20021.0,Acasti Pharma Shares Volatile in Premarket; Up as Much as 109%,2015-10-14 08:45:00-04:00,ACST,positive
20022.0,Acasti Reports 1-For-10 Reverse Stock Split,2015-09-29 07:00:00-04:00,ACST,neutral
20023.0,"Acasti Reports Q4 EPS $(0.02), Rev. $178K vs. Est. $550K",2015-05-27 17:38:00-04:00,ACST,neutral
20024.0,Acasti Receives Extension to Regain Compliance With NASDAQ Minimum Bid Price Rule,2015-05-11 10:49:00-04:00,ACST,neutral
20025.0,Acasti Granted Composition & Use Patent in China,2015-03-25 07:33:00-04:00,ACST,positive
20026.0,Acasti Receives Full Data for Phase II TRIFECTA Trial,2015-03-02 07:31:00-05:00,ACST,neutral
20027.0,Acasti Pharma Gains Ahead Of Expected Phase II Results,2015-02-26 14:24:00-05:00,ACST,positive
20028.0,Acasti Pharma Shares Rise 11% Ahead of Phase 2 Data,2015-02-26 11:07:00-05:00,ACST,positive
20029.0,Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements,2014-11-11 08:10:00-05:00,ACST,neutral
20030.0,Acasti Announces Positive Top-Line Pharmacokinetic Results,2014-09-30 08:05:00-04:00,ACST,positive
20031.0,Acasti Reports Successful CaPre(R) Phase II TRIFECTA Results Proving Statistically Significant Improvements in Triglycerides & Non-HDL-C ,2014-09-29 08:11:00-04:00,ACST,positive
20032.0,Morning Market Movers ,2014-07-09 09:42:00-04:00,ACST,neutral
20033.0,Acasti Announces CFO Resigns,2014-06-16 07:03:00-04:00,ACST,negative
20034.0,"Neptune, Acasti and NeuroBioPharm Announce President, CEO Harland to Resign",2014-04-28 08:09:00-04:00,ACST,negative
20035.0,Neptune Announces Completion of Final Patent Infringement Settlement and License Agreement with Enzymotec ,2014-04-27 20:47:00-04:00,ACST,neutral
20036.0,Neptune & Acasti Give Update on Patent Litigations With Enzymotec ,2014-04-01 14:25:00-04:00,ACST,neutral
20037.0,"Acasti, Neptune Tech Say Settlement Hasn't Been Finalized With Enzymotec",2014-02-14 09:44:00-05:00,ACST,neutral
20038.0,"Neptune, Acasti And Enzymotec Sign Settlement Term Sheet Resulting In Stay Of ITC Investigation For 30 Days",2013-12-18 09:00:00-05:00,ACST,neutral
20039.0,"From Earlier: Neptune, Aker BioMarine Reach Patent Infringement Settlement and License Agreement",2013-12-17 10:31:00-05:00,ACST,positive
20040.0,Acasti Prices 16M Unit Offering at $1.25/Unit,2013-11-27 09:20:00-05:00,ACST,neutral
20041.0,"Shares of Neptune, Acasti to Resume Trade at 10:15AM EDT",2013-10-02 10:10:00-04:00,ACST,positive
20042.0,"Neptune, Acasti Report Settlement with Rimfrost, Neptune Granted Worldwide Non-Exclusive License",2013-10-02 09:47:00-04:00,ACST,positive
20043.0,Shares of Acasti Pharma Halted News Pending,2013-10-02 09:00:00-04:00,ACST,positive
